Morgan Stanley 13D and 13G filings for Terns Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-12 11:11 am Sale | 2026-03-31 | 13G | TERNS PHARMACEUTICALS INC TERN | MORGAN STANLEY MS | 6,433,964 5.600% | -665,990 (-9.38%) | Filing |
| 2025-05-07 11:29 am Purchase | 2025-03-31 | 13G | TERNS PHARMACEUTICALS INC TERN | MORGAN STANLEY MS | 7,099,954 8.100% | 7,099,954 (New Position) | Filing |